Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.
<h4>Unlabelled</h4>Addition of temozolomide (TMZ) to radiation therapy is the standard treatment for patients with glioblastoma (GBM). However, there is uncertainty regarding the effectiveness of TMZ. Considering the rapid evolution of the disease, methods to assess TMZ efficacy early du...
Guardado en:
Autores principales: | Thomas Viel, Sonja Schelhaas, Stefan Wagner, Lydia Wachsmuth, Katrin Schwegmann, Michael Kuhlmann, Cornelius Faber, Klaus Kopka, Michael Schäfers, Andreas H Jacobs |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5b83a89cb35d464b98a1abc32bdbe18f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
por: Bin Huang, et al.
Publicado: (2021) -
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
por: Thomas RP, et al.
Publicado: (2012) -
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide
por: Nadja I. Lorenz, et al.
Publicado: (2021) -
Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
por: Tae Hoon Roh, et al.
Publicado: (2020) -
Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells
por: Selva Rupa Christinal Immanuel, et al.
Publicado: (2021)